Related Articles
Natural phytochemicals as testable therapeutic alternatives for HER‑2‑enriched breast cancer (Review)
Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer (Review)
Targeting drug resistant stem cells in a human epidermal growth factor receptor‑2‑enriched breast cancer model
Stem cell targeted therapeutic approaches for molecular subtypes of clinical breast cancer (Review)
Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells